Coronavirus Disease 2019 - COVID 19
Candidate Vaccines
Last updated on: 31 March 2020Current stage: Phase 1 | ||
Platform | Type of candidate vaccine | Developer |
Non- Replicating Viral Vector | Adenovirus Type 5 Vector | CanSino Biological Inc. and Beijing Institute of Biotechnology |
RNA | LNP- encapsulated mRNA |
Moderna/NIAID |
Current stage: Pre-clinical | ||
Platform | Type of candidate vaccine | Developer |
DNA | DNA plasmid vaccine Electroporation device | Inovio Pharmaceuticals |
DNA | DNA | Takis/Applied DNA Sciences/Evvivax |
DNA | DNA plasmid vaccine | Zydus Cadila |
Inactivated | Formaldehyde- inactivated + alum | Sinovac |
Live Attenuated Virus | Deoptimized live attanuated vaccines | Codagenix/Serum Institute of India |
Non- Replicating Viral Vector | MVA encoded VLP | GeoVax/BravoVax |
Non- Replicating Viral Vector | Ad26 (alone or with MVA boost) | Janssen Pharmaceutical Companies |
Non- Replicating Viral Vector | ChAdOx1 | University of Oxford |
Non- Replicating Viral Vector | adenovirus- based NasoVAX expressing SARS2-CoV spike protein |
Altimmune |
Non- Replicating Viral Vector | Ad5 S (GREVAX™ platform) |
Greffex |
Non- Replicating Viral Vector | Oral Vaccine platform | Vaxart |
Protein Subunit | Drosophila S2 insect cell expression system VLPs | ExpreS2ion |
Protein Subunit | S protein | WRAIR/USAMRIID |
Protein Subunit | S-Trimer | Clover Biopharmaceuticals Inc./GSK |
Protein Subunit | Peptide | Vaxil Bio |
Protein Subunit | S protein | AJ Vaccines |
Protein Subunit | Ii-Key peptide | Generex/EpiVax |
Protein Subunit | S protein | EpiVax/Univ. of Georgia |
Protein Subunit | S protein (baculovirus production) | Sanofi Pasteur |
Protein Subunit | Full length S trimers/ nanoparticle + Matrix M | Novavax |
Protein Subunit | gp-96 backbone | Heat Biologics/Univ. Of Miami |
Protein Subunit | Molecular clamp stabilized Spike protein | University of Queensland/GSK |
Protein Subunit | S1 or RBD protein |
Baylor College of Medicine |
Protein Subunit | Subunit protein, plant produced | iBio/CC-Pharming |
Protein Subunit | Subunit | VIDO-InterVac, University of Saskatchewan |
Protein Subunit | Adjuvanted microsphere peptide | University of Saskatchewan |
Replicating Viral Vector | Measles Vector | Zydus Cadila |
Replicating Viral Vector | Measles Vector | Institute Pasteur/Themis/Univ. of Pittsburg Center for Vaccine Research |
Replicating Viral Vector | Horsepox vector expressing S protein | Tonix Pharma/Southern Research |
RNA | LNP- encapsulated mRNA cocktail encoding VLP |
Fudan University/ Shanghai JiaoTong University/RNACure Biopharma |
RNA | LNP- encapsulated mRNA encoding RBD |
Fudan University/ Shanghai JiaoTong University/RNACure Biopharma |
RNA | mRNA | China CDC/Tongji University/Stermina |
RNA | mRNA | Arcturus/Duke-NUS |
RNA | mRNA | BioNTech/Fosun Pharma/Pfizer |
RNA | saRNA | Imperial College London |
RNA | mRNA | Curevac |
VLP | Plant-derived VLP | Medicago Inc. |
Unknown | Unknown | University of Hong Kong |
Unknown | Unknown | ImmunoPrecise |
Unknown | Unknown | MIGAL Galilee Research Institute |
Unknown | Unknown | Doherty Institute |
Unknown | Unknown | Tulane University |
All vaccines are targetted at COVID-19 |
Ref: https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1
Designed by Dr. Serin Kuriakose © All rights reserved 2020. Contact us at admin@afpikerala.in